· investment-strategies · 3 min read
Cambridge Aerospace’s $300M Series C at $3.4B: Cheap Interceptors vs Expensive Missiles
DFJ Growth led Cambridge Aerospace’s $300M Series C as Lux, Accel, and Lakestar returned — Skyhammer sells low-cost air defence against Shahed-class drones.
Cambridge Aerospace closed a $300 million Series C at a $3.4 billion valuation around August 10, 2026, led by DFJ Growth, with returning capital from Lux Capital, Accel, Lakestar, Never Lift, Ora Global, and Elad Gil. The Cambridge, UK company is selling a simple budget story: stop firing $1M interceptors at ~$20K attack drones.
Key facts
| Field | Detail |
|---|---|
| Company | Cambridge Aerospace (Cambridge, UK) |
| Round | $300M Series C · $3.4B valuation |
| Date | August 10, 2026 |
| Lead | DFJ Growth |
| Returning / key | Lux Capital, Accel, Lakestar, Never Lift, Ora Global, Elad Gil |
| Prior | $200M Series B @ $1.3B (April 2026); ~$636M cumulative |
| Product | Skyhammer (drone interceptor), Starhammer, Looking Glass radar, Nightstar motors |
| Traction | Multi-million UK MoD contract; 250+ employees across UK, Germany, Poland, Norway, Ukraine, Australia |
| Founded | 2024 (Steven Barrett, Chris Sylvan, Junaid Hussain) |
Who uses the product — and for what job
Users: defense ministries, armed forces procurement offices, and allied programs buying air defence that matches the economics of mass drones.
Job: intercept Shahed-class and similar cheap UAVs at a cost that does not bankrupt the defender — then expand into faster missile intercept and sensing (Starhammer, Looking Glass).
Skyhammer is already in the UK’s Low-Cost Effectors & Autonomous Platforms lane. That is not a pitch deck claim; it is a named customer with a delivery mandate.
Why now
- Drone attrition warfare made the cost-exchange ratio a board-level NATO problem, not a niche R&D topic.
- Europe’s defense-tech unicorns (Helsing, Quantum Systems, Stark) raised offensive or battlefield stacks; cheap defensive effectors were still under-financed relative to need.
- UK industrial policy (“unicorn scheme,” broader startup defense spending) is actively buying local manufacturing capacity.
- Series B at $1.3B was only four months earlier — manufacturing and contract delivery, not more science theater, is the Series C job.
Why these investors — portfolio fit
DFJ Growth as new lead is the growth-equity tell: the firm’s public comps include Anduril and SpaceX — national-security hardware that must ship at volume.
Lux Capital returning fits its frontier deep-tech / defense mandate already documented on our fund page. Accel and Lakestar returning keeps European multi-stage ownership intact.
Likely founder rationale: take a U.S. growth lead that knows how to finance defense manufacturing scale without replacing the European syndicate that financed the MoD path.
| Dimension | Fit |
|---|---|
| Thesis | Physical national security with unit-economics edge |
| Stage | Manufacturing + contract delivery after product-market proof |
| Geography | UK HQ with allied basing — Lux/Accel already comfortable cross-Atlantic |
| Risk | Hardware yield, export controls, peer competition from offensive unicorns entering defense |
We do not list DFJ Growth as a /fund/ entity today — name is press-sourced.
Competitive map
| Player | Lane |
|---|---|
| Legacy missile primes | High-performance, high-cost interceptors |
| Aurelius Systems / directed energy | Lasers vs kinetic interceptors — different physics, same buyer pain |
| Helsing / Stark / Quantum Systems | Mostly offense / autonomy stacks; Cambridge is defensive effectors |
| Traditional SHORAD programs | Incumbent procurement cycles; slower cost curves |
When not to underwrite this like SaaS
- Wrong if you model ARR multiples — this is contracted hardware + industrial capacity.
- Wrong if “$3.4B in under two years” is treated as proof of unit economics without delivery data.
- Wrong if you assume NATO budgets automatically clear every European defense unicorn at once — capital and factory time are finite.
Practical takeaway
- Founders (defense): Sell the cost-per-kill math with a named MoD path; growth capital follows contracts, not demos.
- Investors: Underwrite manufacturing schedule and allied demand concentration — valuation jumped 2.6× in four months; delivery risk is the thesis.
- Operators / scouts: Pair this with laser/C-UAS peers (Aurelius) — buyers will mix kinetic and directed energy.